NewsRoom Articles - Page 38 of 154 - PsychedelicNewsWire (PNW)

WednesdayFeb 22, 2023 12:52 pm

Studies Explore the Use of Psychedelics in Delaying or Reversing Aging

Aging is the number one cause of suffering and death globally, as noted by Dr. Andrew Steele, who authored a book on longevity. Steele, who’s majored in physics, argues that people could live to 200 if we came up with pharmacological solutions to eliminate the cells that degrade tissue function. One study carried out by scientists at Harvard Medical School found that epigenetics could drive aging in an organism. The research, which used mice models, demonstrated that a breakdown in epigenetic data caused the animals to age. The researchers also observed that reinstating the integrity of the epigenome reversed these…

WednesdayFeb 22, 2023 12:16 pm

Marigold PR hosts International Women’s Day Event for Cannabis and Psychedelics Industry

Women working in Cannabis and Psychedelics celebrate International Women’s Day with virtual networking event Marigold Marketing & PR, committed to support advancing women in emerging industries has announced it is hosting MarigoldLIVE: International Women’s Day. A virtual event, MarigoldLIVE: International Women’s Day, is open to audiences worldwide and will take place 2:00-4:30 p.m. EST on Wednesday, March 8th, 2023. The event will offer attendees a unique experience, providing collaboration, networking, inspiration, and advice for women's success in the emerging cannabis and psychedelics industries worldwide. “We’re thrilled to be hosting our fourth annual International Women’s Day event. Through our events we’ve…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

TuesdayFeb 21, 2023 12:00 pm

Why Mescaline Studies Are Few

Scores of studies on the therapeutic potential of psychedelic substances have been conducted these last 20 years, with promising results showing that drugs such as MDMA, LSD and psilocybin may be useful in the treatment of various mental health conditions. These positive findings have fueled the psychedelics decriminalization and legalization movement greatly, despite the fact that the substances are illegal at the federal level. While numerous studies have been done on classic psychedelics, not enough studies have featured mescaline. Mescaline is a naturally occurring psychedelic that induces hallucinogenic effects when consumed. Some pharmacological companies and researchers have been trying to…

FridayFeb 17, 2023 11:26 am

New Study Finds That Psilocybin Creates Strong Ties to Nature in Users

Psychedelics have been subject to an increasing amount of research in recent years in the wake of widespread drug reform. Although most psychedelic research is still in its infancy, current studies have revealed that hallucinogenic drugs are capable of inducing profound and long-term insights in users with minimal doses. This makes psychedelics a viable treatment for a variety of mental health disorders, with studies showing that these substances are useful in the treatment and management of symptoms of conditions such as post-traumatic stress disorder, anxiety and treatment-resistant depression. Researchers have posited that these benefits are derived from the fact that…

ThursdayFeb 16, 2023 2:52 pm

Study Finds That Psilocybin May Reduce Suppressive Thoughts in Depressed Individuals

A surge of psychedelic research over the past decade has revealed what some scientists in the late 1950s and early 19960s suspected: hallucinogens have protective mental health properties. Groundbreaking research in recent years has shown that classic psychedelics such as DMT, psilocybin, ketamine and LSD have the potential to treat severe mental health conditions. And while pharmaceutical medications take days or even weeks of consistent dosing to kick in, psychedelics offer relatively immediate relief from symptoms with minimal doses. Consequently, millions of dollars have been allocated for the research and development of mental treatments that leverage the protective properties of…

WednesdayFeb 15, 2023 12:46 pm

More States Join Push for Psychedelics Policy Reform

Psychedelics have become very popular amid the reform movement. Legislators in different states across the country have even introduced measures to decriminalize and legalize psychedelics in an effort to stop criminalizing individuals over these drugs as well as allow their recreational and medicinal use. Numerous studies have shown that psychedelics such as psilocybin and MDMA could be useful in the treatment of mental health conditions, including anxiety, depression and post-traumatic stress disorder. Below, we look at some of the latest developments on policy reform in different states thus far. Missouri Last week, Senator Thompson Rehder introduced a measure that would…

TuesdayFeb 14, 2023 1:50 pm

Tim Ferris, Other Notables to Attend Denver Psychedelics Conference

After decades of prohibition by most territories, psychedelics are finally seeing a surge in interest among the scientific and mainstream communities. Initial research into the potential risks and benefits of psychedelic drugs has revealed that they may be able to alleviate the symptoms of a variety of mental health disorders. While this research is still in its infancy, it has shown that psychedelics have significant potential as mental health treatment, especially when paired with psychotherapy. Stakeholders, entrepreneurs and anyone else interested in psychedelics will have the chance to learn everything about them during the upcoming Psychedelic Sciences conference. The conference…

MondayFeb 13, 2023 1:34 pm

Psychedelics Are Proving Their Mettle Against Trauma, Anxiety

The past two decades have been characterized by numerous drug reform initiatives that have resulted in controlled substances such as cannabis and psychedelics being recognized for their medical potential. While there has been a decent amount of research into cannabis thanks to loosening reforms across the country, psychedelic research is still in its infancy. Despite this limited research, hallucinogens have exhibited immense potential as treatments against a variety of mental health conditions in initial studies. The result has been a surge of research into the potential benefits and risks of using psychedelics to treat mental disorders such as depression, post-traumatic…

FridayFeb 10, 2023 12:08 pm

UC Davis Launches Institute for Psychedelic Studies

After decades of criminalization by federal and state governments, psychedelics are finally seeing their day in the sun. Early research into psychedelics carried out in the late 1950s and early 1960s revealed that these substances may have some mental health benefits, but criminalization prevented researchers from studying hallucinogenic drugs further. In recent years, a renaissance of psychedelic research has shown that these drugs can have profound and long-term benefits in the treatment of several mental health conditions, especially when they are paired with psychotherapy. This has resulted in a flurry of action among institutions across the world. Big Pharma and…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000